Florence Healthcare has achieved a significant milestone in the realm of clinical trial operations. The Florence Trial Operations Platform now links over 65,000 study sites with more than 600 sponsors across over 90 countries, establishing it as the largest network in the industry.
This development marks a pivotal moment for clinical trial intelligence, driven by advancements in artificial intelligence (AI) that streamline study startup processes, automate workflows, and enhance operational risk management. Recognized as the leading clinical trial technology for six consecutive years, Florence continues to set benchmarks for efficiency and effectiveness in study management.
With such a vast network, Florence is poised to revolutionize how clinical trials are conducted, allowing for faster initiation and improved oversight of sponsor study portfolios. The integration of AI technologies within the platform enables a more agile response to the evolving demands of clinical research, ultimately aiming to improve outcomes for patients and researchers alike.
This expansion not only underscores Florence Healthcare”s commitment to innovation but also enhances the collaborative efforts of sponsors and study sites in delivering timely and effective clinical trials globally.
